Immucor sells investment in instrument manufacturer:
This article was originally published in Clinica
Blood analysis equipment maker Immucor has sold its stake in Lionheart Technologies for about $1.3m. It was bought by Lionheart, the owner of Bio-Tek Instruments, one of Immucor's development and manufacturing partners. Winooski, Vermont-based Bio-Tek manufactures Immucor's ABS2000 automated blood bank laboratory analyser, and is developing a third-generation automated assay instrument for small to medium-sized hospitals. Bio-Tek's vice-president of business development, Adam Alpert, said the company "anticipate[d] no changes in this relationship as a consequence of the stock sale".
You may also be interested in...
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.